Medchemexpress LLC 1-(4-Fluorophenyl)-N-methyl-N-[4[[(phenylamino)carbonyl]amino]phenyl]-1H-pyrazole-4-sulfonamide | 1259028-99-3 | MFCD28166480 | 99.0% | 465.50 g·mol⁻¹ | C23H20FN5O3S | 5 MG

Supplier:  Medchemexpress LLC HY1101125MG

BTT-3033 is an orally active, conformation-selective small-molecule inhibitor of the integrin α2β1 that binds the α2 I domain (reported EC50 ≈130 nM). It inhibits platelet binding to collagen I, reduces cell proliferation, and can induce apoptosis; intended for research use only.

• Selective α2β1 integrin inhibition with low-nanomolar activity.
• Orally active small-molecule format suitable for in vivo or in vitro studies.
• High reported purity (~99.0%) for reproducible results.
• Good solubility in DMSO (≈250 mg/mL) for preparation of stock solutions.
• Powder is stable at -20°C for extended storage; solutions require cold storage.
• Available in small mg quantities and as prepared DMSO solution for convenient dosing.

Catalog No. 50-002-64173